Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability
出版年份 2018 全文链接
标题
Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability
作者
关键词
-
出版物
Journal of Diabetes Research
Volume 2018, Issue -, Pages 1-17
出版商
Hindawi Limited
发表日期
2018-07-05
DOI
10.1155/2018/1205121
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Can the upper inner side of the thigh become a new option for insulin injection?
- (2016) Jingyun Yuan et al. CURRENT MEDICAL RESEARCH AND OPINION
- Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control
- (2016) Susanne Famulla et al. DIABETES CARE
- New Long-Acting Basal Insulins: Does Benefit Outweigh Cost?
- (2016) Eberhard Standl et al. DIABETES CARE
- Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes
- (2016) Tim Heise et al. DIABETES OBESITY & METABOLISM
- New Insulin Delivery Recommendations
- (2016) Anders H. Frid et al. MAYO CLINIC PROCEEDINGS
- Addition of 20-kDa PEG to Insulin Lispro Alters Absorption and Decreases Clearance in Animals
- (2016) Mary Pat Knadler et al. PHARMACEUTICAL RESEARCH
- Concentrated insulins: the new basal insulins
- (2016) Stephen Davis et al. Therapeutics and Clinical Risk Management
- Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5
- (2015) John B. Buse et al. DIABETES CARE
- Low within- and between-day variability in exposure to new insulin glargine 300 U/ml
- (2015) R. H. A. Becker et al. DIABETES OBESITY & METABOLISM
- Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes
- (2015) H. M. de Wit et al. DIABETES OBESITY & METABOLISM
- Effects of insulin degludec and insulin glargine on day-to-day fasting plasma glucose variability in individuals with type 1 diabetes: a multicentre, randomised, crossover study
- (2015) Tomoaki Nakamura et al. DIABETOLOGIA
- Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
- (2015) Christopher James Rini et al. Drug Delivery and Translational Research
- Individualizing Insulin Therapy in the Management of Type 2 Diabetes
- (2014) Etie Moghissi et al. AMERICAN JOURNAL OF MEDICINE
- Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region
- (2014) Leszek Nosek et al. CLINICAL DRUG INVESTIGATION
- New Insulin Glargine 300 units{middle dot}mL-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 units{middle dot}mL-1
- (2014) R. H. A. Becker et al. DIABETES CARE
- Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial
- (2014) T. Heise et al. DIABETES OBESITY & METABOLISM
- Insulin aspart pharmacokinetics: An assessment of its variability and underlying mechanisms
- (2014) Christian Hove Rasmussen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Effects of Age, Gender, BMI, and Anatomical Site on Skin Thickness in Children and Adults with Diabetes
- (2014) José G. B. Derraik et al. PLoS One
- A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec
- (2013) Stefan Korsatko et al. CLINICAL DRUG INVESTIGATION
- Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes
- (2013) M. Blanco et al. DIABETES & METABOLISM
- Needle-Free Jet Injection of Rapid-Acting Insulin Improves Early Postprandial Glucose Control in Patients With Diabetes
- (2013) E. E. C. Engwerda et al. DIABETES CARE
- PEGylated insulin Lispro, (LY2605541)-a new basal insulin analogue
- (2013) T. M. Caparrotta et al. DIABETES OBESITY & METABOLISM
- Variability of glucose-lowering effect as a limiting factor in optimizing basal insulin therapy: a review
- (2013) J. Vora et al. DIABETES OBESITY & METABOLISM
- Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus
- (2013) V. P. Sinha et al. DIABETES OBESITY & METABOLISM
- Faster In and Faster Out: Accelerating Insulin Absorption and Action by Insulin Infusion Site Warming
- (2013) Eda Cengiz et al. Diabetes Technology & Therapeutics
- Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
- (2012) Wolfgang F. Richter et al. AAPS Journal
- Ultrastructural Visualization of Insulin Degludec Multi-hexamers in the Subcutaneous Depot In Vivo Supports a Unique Mechanism of Protraction
- (2012) Torben Seested et al. Canadian Journal of Diabetes
- Enhanced Absorption of Insulin Aspart as the Result of a Dispersed Injection Strategy Tested in a Randomized Trial in Type 1 Diabetic Patients
- (2012) J. K. Mader et al. DIABETES CARE
- Body mass index and the efficacy of needle-free jet injection for the administration of rapid-acting insulin analogs, apost hocanalysis
- (2012) B. E. de Galan et al. DIABETES OBESITY & METABOLISM
- Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes
- (2012) T. Heise et al. DIABETES OBESITY & METABOLISM
- Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes
- (2012) T. Heise et al. DIABETES OBESITY & METABOLISM
- Regulation of subcutaneous adipose tissue blood flow during exercise in humans
- (2012) Ilkka Heinonen et al. JOURNAL OF APPLIED PHYSIOLOGY
- Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
- (2012) Ib Jonassen et al. PHARMACEUTICAL RESEARCH
- Metabolic characteristics of human subcutaneous abdominal adipose tissueafter overnight fast
- (2011) Keith N. Frayn et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Increased Adipose Tissue Oxygen Tension in Obese Compared With Lean Men Is Accompanied by Insulin Resistance, Impaired Adipose Tissue Capillarization, and Inflammation
- (2011) Gijs H. Goossens et al. CIRCULATION
- Accelerated Insulin Pharmacokinetics and Improved Postprandial Glycemic Control in Patients With Type 1 Diabetes After Coadministration of Prandial Insulins With Hyaluronidase
- (2011) M. Hompesch et al. DIABETES CARE
- Rapid Pharmacokinetics of Intradermal Insulin Administered Using Microneedles in Type 1 Diabetes Subjects
- (2011) Jyoti Gupta et al. Diabetes Technology & Therapeutics
- Intradermal Microneedle Delivery of Insulin Lispro Achieves Faster Insulin Absorption and Insulin Action than Subcutaneous Injection
- (2011) Ronald J. Pettis et al. Diabetes Technology & Therapeutics
- Improved Postprandial Glycemic Control in Patients with Type 2 Diabetes from Subcutaneous Injection of Insulin Lispro with Hyaluronidase
- (2011) Marcus Hompesch et al. Diabetes Technology & Therapeutics
- Bioavailability and variability of biphasic insulin mixtures
- (2011) Tue Søeborg et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Dose-Dependent Delay of the Hypoglycemic Effect of Short-Acting Insulin Analogs in Obese Subjects With Type 2 Diabetes: A pharmacokinetic and pharmacodynamic study
- (2010) M. Gagnon-Auger et al. DIABETES CARE
- Defining the Ideal Injection Techniques When Using 5-mm Needles in Children and Adults
- (2010) P. L. Hofman et al. DIABETES CARE
- Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes
- (2010) S M Ocheltree et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature
- (2009) L. Nalysnyk et al. DIABETES OBESITY & METABOLISM
- Absorption kinetics of insulin after subcutaneous administration
- (2008) Tue Søeborg et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started